Why are slowing the rate of gastric emptying and suppressing glucagon secretion important?
These actions are poorly regulated in patients with type 2 diabetes. Dysfunctional gastric emptying and excess glucagon secretion in type 2 diabetes contribute to poor glycemic control. Through multiple mechanisms of action, BYETTA addresses many of these concerns and leads to improved glycemic control, including A1C reduction.